Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases

Victor V. Revin, Natalia V. Gromova, Elvira S. Revina, Maria I. Martynova, Angelina I. Seikina, Nadezhda V. Revina, Oksana G. Imarova, Ilia N. Solomadin, Alexander Yu. Tychkov, Nikolai Zhelev

Research output: Contribution to journalArticle

7 Citations (Scopus)
14 Downloads (Pure)

Abstract

The composition and condition of membrane lipids, the morphology of erythrocytes, and hemoglobin distribution were explored with the help of laser interference microscopy (LIM) and Raman spectroscopy. It is shown that patients with cardiovascular diseases (CVD) have significant changes in the composition of their phospholipids and the fatty acids of membrane lipids. Furthermore, the microviscosity of the membranes and morphology of the erythrocytes are altered causing disordered oxygen transport by hemoglobin. Basic therapy carried out with the use of antiaggregants, statins, antianginals, beta-blockers, and calcium antagonists does not help to recover themorphofunctional properties of erythrocytes. Based on the results the authors assume that, for the relief of the ischemic crisis and further therapeutic treatment, it is necessary to include, in addition to cardiovascular disease medicines, medication that increases the ability of erythrocytes’ hemoglobin to transport oxygen to the tissues. We assume that the use of LIM and Raman spectroscopy is advisable for early diagnosis of changes in the structure and functional state of erythrocytes when cardiovascular diseases develop.
Original languageEnglish
Article number3429604
Number of pages11
JournalBioMed Research International
Volume2016
DOIs
Publication statusPublished - 4 Oct 2016

Fingerprint

Membrane Lipids
Hemoglobins
Cardiovascular Diseases
Erythrocytes
Interference Microscopy
Oxygen
Raman spectroscopy
Raman Spectrum Analysis
Microscopic examination
Confocal Microscopy
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lasers
Chemical analysis
Medicine
Phospholipids
Erythrocyte Membrane
Fatty Acids
Tissue
Calcium
Membranes

Cite this

Revin, V. V., Gromova, N. V., Revina, E. S., Martynova, M. I., Seikina, A. I., Revina, N. V., ... Zhelev, N. (2016). Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases. BioMed Research International, 2016, [3429604]. https://doi.org/10.1155/2016/3429604
Revin, Victor V. ; Gromova, Natalia V. ; Revina, Elvira S. ; Martynova, Maria I. ; Seikina, Angelina I. ; Revina, Nadezhda V. ; Imarova, Oksana G. ; Solomadin, Ilia N. ; Tychkov, Alexander Yu. ; Zhelev, Nikolai. / Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases. In: BioMed Research International. 2016 ; Vol. 2016.
@article{7fa03a27675b4c59a02f49a538086f4e,
title = "Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases",
abstract = "The composition and condition of membrane lipids, the morphology of erythrocytes, and hemoglobin distribution were explored with the help of laser interference microscopy (LIM) and Raman spectroscopy. It is shown that patients with cardiovascular diseases (CVD) have significant changes in the composition of their phospholipids and the fatty acids of membrane lipids. Furthermore, the microviscosity of the membranes and morphology of the erythrocytes are altered causing disordered oxygen transport by hemoglobin. Basic therapy carried out with the use of antiaggregants, statins, antianginals, beta-blockers, and calcium antagonists does not help to recover themorphofunctional properties of erythrocytes. Based on the results the authors assume that, for the relief of the ischemic crisis and further therapeutic treatment, it is necessary to include, in addition to cardiovascular disease medicines, medication that increases the ability of erythrocytes’ hemoglobin to transport oxygen to the tissues. We assume that the use of LIM and Raman spectroscopy is advisable for early diagnosis of changes in the structure and functional state of erythrocytes when cardiovascular diseases develop.",
author = "Revin, {Victor V.} and Gromova, {Natalia V.} and Revina, {Elvira S.} and Martynova, {Maria I.} and Seikina, {Angelina I.} and Revina, {Nadezhda V.} and Imarova, {Oksana G.} and Solomadin, {Ilia N.} and Tychkov, {Alexander Yu.} and Nikolai Zhelev",
year = "2016",
month = "10",
day = "4",
doi = "10.1155/2016/3429604",
language = "English",
volume = "2016",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

Revin, VV, Gromova, NV, Revina, ES, Martynova, MI, Seikina, AI, Revina, NV, Imarova, OG, Solomadin, IN, Tychkov, AY & Zhelev, N 2016, 'Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases', BioMed Research International, vol. 2016, 3429604. https://doi.org/10.1155/2016/3429604

Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases. / Revin, Victor V.; Gromova, Natalia V.; Revina, Elvira S.; Martynova, Maria I.; Seikina, Angelina I.; Revina, Nadezhda V.; Imarova, Oksana G.; Solomadin, Ilia N.; Tychkov, Alexander Yu.; Zhelev, Nikolai.

In: BioMed Research International, Vol. 2016, 3429604, 04.10.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases

AU - Revin, Victor V.

AU - Gromova, Natalia V.

AU - Revina, Elvira S.

AU - Martynova, Maria I.

AU - Seikina, Angelina I.

AU - Revina, Nadezhda V.

AU - Imarova, Oksana G.

AU - Solomadin, Ilia N.

AU - Tychkov, Alexander Yu.

AU - Zhelev, Nikolai

PY - 2016/10/4

Y1 - 2016/10/4

N2 - The composition and condition of membrane lipids, the morphology of erythrocytes, and hemoglobin distribution were explored with the help of laser interference microscopy (LIM) and Raman spectroscopy. It is shown that patients with cardiovascular diseases (CVD) have significant changes in the composition of their phospholipids and the fatty acids of membrane lipids. Furthermore, the microviscosity of the membranes and morphology of the erythrocytes are altered causing disordered oxygen transport by hemoglobin. Basic therapy carried out with the use of antiaggregants, statins, antianginals, beta-blockers, and calcium antagonists does not help to recover themorphofunctional properties of erythrocytes. Based on the results the authors assume that, for the relief of the ischemic crisis and further therapeutic treatment, it is necessary to include, in addition to cardiovascular disease medicines, medication that increases the ability of erythrocytes’ hemoglobin to transport oxygen to the tissues. We assume that the use of LIM and Raman spectroscopy is advisable for early diagnosis of changes in the structure and functional state of erythrocytes when cardiovascular diseases develop.

AB - The composition and condition of membrane lipids, the morphology of erythrocytes, and hemoglobin distribution were explored with the help of laser interference microscopy (LIM) and Raman spectroscopy. It is shown that patients with cardiovascular diseases (CVD) have significant changes in the composition of their phospholipids and the fatty acids of membrane lipids. Furthermore, the microviscosity of the membranes and morphology of the erythrocytes are altered causing disordered oxygen transport by hemoglobin. Basic therapy carried out with the use of antiaggregants, statins, antianginals, beta-blockers, and calcium antagonists does not help to recover themorphofunctional properties of erythrocytes. Based on the results the authors assume that, for the relief of the ischemic crisis and further therapeutic treatment, it is necessary to include, in addition to cardiovascular disease medicines, medication that increases the ability of erythrocytes’ hemoglobin to transport oxygen to the tissues. We assume that the use of LIM and Raman spectroscopy is advisable for early diagnosis of changes in the structure and functional state of erythrocytes when cardiovascular diseases develop.

U2 - 10.1155/2016/3429604

DO - 10.1155/2016/3429604

M3 - Article

VL - 2016

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 3429604

ER -